These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 12533032)

  • 1. Autoimmune phenomena in patients with myelodysplastic syndromes and chronic myelomonocytic leukemia.
    Saif MW; Hopkins JL; Gore SD
    Leuk Lymphoma; 2002 Nov; 43(11):2083-92. PubMed ID: 12533032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoimmune phenomena in patients with myelodysplastic syndromes.
    Enright H; Miller W
    Leuk Lymphoma; 1997 Feb; 24(5-6):483-9. PubMed ID: 9086438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paraneoplastic autoimmune phenomena in patients with myelodysplastic syndromes: response to immunosuppressive therapy.
    Enright H; Jacob HS; Vercellotti G; Howe R; Belzer M; Miller W
    Br J Haematol; 1995 Oct; 91(2):403-8. PubMed ID: 8547082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Systemic and autoimmune manifestations in myelodysplastic syndromes].
    Fain O; Braun T; Stirnemann J; Fenaux P
    Rev Med Interne; 2011 Sep; 32(9):552-9. PubMed ID: 20850913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic inflammatory demyelinating polyneuropathy accompanied by chronic myelomonocytic leukemia: possible pathogenesis of autoimmunity in myelodysplastic syndrome.
    Isoda A; Sakurai A; Ogawa Y; Miyazawa Y; Saito A; Matsumoto M; Sawamura M
    Int J Hematol; 2009 Sep; 90(2):239-242. PubMed ID: 19588217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic inflammatory and autoimmune manifestations associated with myelodysplastic syndromes and chronic myelomonocytic leukaemia: a French multicentre retrospective study.
    Mekinian A; Grignano E; Braun T; Decaux O; Liozon E; Costedoat-Chalumeau N; Kahn JE; Hamidou M; Park S; Puéchal X; Toussirot E; Falgarone G; Launay D; Morel N; Trouiller S; Mathian A; Gombert B; Schoindre Y; Lioger B; De Wazieres B; Amoura Z; Buchdaul AL; Georgin-Lavialle S; Dion J; Madaule S; Raffray L; Cathebras P; Piette JC; Rose C; Ziza JM; Lortholary O; Montestruc F; Omouri M; Denis G; Rossignol J; Nimubona S; Adès L; Gardin C; Fenaux P; Fain O
    Rheumatology (Oxford); 2016 Feb; 55(2):291-300. PubMed ID: 26350487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased cardiovascular comorbidities in patients with myelodysplastic syndromes and chronic myelomonocytic leukemia presenting with systemic inflammatory and autoimmune manifestations.
    Kipfer B; Daikeler T; Kuchen S; Hallal M; Andina N; Allam R; Bonadies N
    Semin Hematol; 2018 Oct; 55(4):242-247. PubMed ID: 30502853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunologic phenomena as the first sign of myelodysplastic syndrome].
    van Rijn RS; Wittebol S; Graafland AD; Kramer MH
    Ned Tijdschr Geneeskd; 2001 Aug; 145(32):1529-33. PubMed ID: 11525083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Systemic diseases in myelodysplastic syndromes].
    Hebbar M; Hebbar-Savéan K; Fenaux P
    Rev Med Interne; 1995; 16(12):897-904. PubMed ID: 8570952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic vasculitis in myelodysplastic syndromes.
    Oostvogels R; Petersen EJ; Chauffaille ML; Abrahams AC
    Neth J Med; 2012 Mar; 70(2):63-8. PubMed ID: 22418751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myelodysplastic Syndromes (MDS) and autoimmune disorders (AD): cause or consequence?
    Braun T; Fenaux P
    Best Pract Res Clin Haematol; 2013 Dec; 26(4):327-36. PubMed ID: 24507810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paraneoplastic inflammation in myelodysplastic syndrome or bone marrow failure: case series with focus on 5-azacytidine and literature review.
    Frietsch JJ; Dornaus S; Neumann T; Scholl S; Schmidt V; Kunert C; Sayer HG; Hochhaus A; La Rosée P
    Eur J Haematol; 2014 Sep; 93(3):247-59. PubMed ID: 24635656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Skin manifestations associated with myelodysplastic syndromes].
    Morand JJ; Lightburn E; Richard MA; Hesse-Bonerandi S; Carsuzaa F; Grob JJ
    Rev Med Interne; 2001 Sep; 22(9):845-53. PubMed ID: 11599186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigating historic cases of pyoderma gangrenosum in myelodysplastic syndrome and chronic myelomonocytic leukemia for possible VEXAS syndrome: A systematic review.
    Croitoru DO; Huang RS; McMullen EP; Maazi M; Piguet V
    J Am Acad Dermatol; 2024 Oct; 91(4):712-714. PubMed ID: 38906261
    [No Abstract]   [Full Text] [Related]  

  • 15. Myelodysplastic syndrome associated with relapsing polychondritis: unusual transformation from refractory anemia to chronic myelomonocytic leukemia.
    Shirota T; Hayashi O; Uchida H; Tonozuka N; Sakai N; Itoh H
    Ann Hematol; 1993 Jul; 67(1):45-7. PubMed ID: 8334199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunological abnormalities in myelodysplastic syndromes. Prospective study (series of 40 patients)].
    Bouali F; Berrah A; Si Ahmed-Bouali D; Harrieche F; Benhalima M; Hamladji RM; Arrada M
    Rev Med Interne; 2005 Oct; 26(10):777-83. PubMed ID: 16203055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Myelodysplastic syndromes and autoimmunity].
    Stalder G; Alberio L; Ribi C
    Rev Med Suisse; 2015 Apr; 11(469):820-2, 824-5. PubMed ID: 26040163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Not all cases of idiopathic thrombocytopenic purpura [correction of pupura] are what they might first seem.
    Mainwaring CJ; Shutt J; James CM
    Clin Lab Haematol; 2002 Aug; 24(4):261-2. PubMed ID: 12181032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory disorders associated with trisomy 8-myelodysplastic syndromes: French retrospective case-control study.
    Wesner N; Drevon L; Guedon A; Fraison JB; Trad S; Kahn JE; Aouba A; Gillard J; Ponsoye M; Hanslik T; Gourguechon C; Liozon E; Laribi K; Rossignol J; Hermine O; Adès L; Carrat F; Fenaux P; Mekinian A; Fain O;
    Eur J Haematol; 2019 Jan; 102(1):63-69. PubMed ID: 30218579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoimmune phenomena in myelodysplastic syndromes: a 4-yr prospective study.
    Giannouli S; Voulgarelis M; Zintzaras E; Tzioufas AG; Moutsopoulos HM
    Rheumatology (Oxford); 2004 May; 43(5):626-32. PubMed ID: 14983106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.